(Q34453059)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Mariarosaria Bucci

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Giuseppe Cirino

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

S Fiorucci

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

1433-1438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Nonsteroidal anti-inflammatory drugs. Tailoring therapy to achieve results and avoid toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Distribution of COX-1 and COX-2 in normal and inflamed tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Leukotrienes and Prostaglandins in Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Nociception in cyclooxygenase isozyme-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Fish oil fatty acids and cardiovascular function: epidemiology and biochemical mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Slow reacting substances of anaphylaxis: Identification of leukotrienes C-1 and D from human and rat sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Leukotrienes as a target in asthma therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

BLTR mediates leukotriene B(4)-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

The PPARalpha-leukotriene B4 pathway to inflammation control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Interactions between prostaglandins and leukotrienes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Bronchodilator activity of a PGE2 analog in animals and in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

The effects of ML 3000 on antigen-induced responses in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Effects of ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor, on indices of early articular lesion in MRL/MpJ-lpr/lpr mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Cytokine-modulating activity of tepoxalin, a new potential antirheumatic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

(6,7-Diaryldihydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

ML 3000 reduces gastric prostaglandin synthesis without causing mucosal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

Adaptation in the Pharmaceutical Industry, with Particular Reference to Gastrointestinal Drugs and Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900747-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(01)00747-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728379%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference